Expression of the coreceptors CD4 and CD8 correlates with the functional phenotype of T cells. Understanding the transcriptional regulation of Cd4 and the adjacent genes Cd8a and Cd8b1 (collectively called 'Cd8' here) might therefore provide insight into the cell-fate 'decision' of DP thymocytes [1] [2] [3] . CD8 expression is tightly regulated during thymocyte development by the activity of at least five different cisregulatory elements 4, 5 . Combined deletion of certain Cd8 enhancers leads to variegated expression of CD8 in CD4 + CD8 + double-positive (DP) thymocytes [6] [7] [8] , and CD8 variegation correlates with an epigenetic 'off ' state 9 . Such studies indicate that there is a complex regulatory network of developmental stage-and subset-specific cis-regulatory elements and link Cd8 enhancer function with chromatin remodeling of the Cd8 gene complex 10 . The transcriptional regulator MAZR (also called PATZ1 or Zfp278) seems to be one of the factors involved in keeping the local chromatin at the Cd8 loci in a transcriptional 'off ' state at the CD4 -CD8 -double-negative (DN) stage 9 . MAZR is encoded by Patz1 (called 'Mazr' here) and belongs to the family of zinc-finger factors that contain a BTB (POZ) domain 11, 12 . Mazr is expressed in the brain, thymocytes and B cells 13 . A study has also reported that MAZR is essential for spermatogenesis 14 . In DN thymocytes, MAZR interacts with several Cd8 cis-regulatory elements. MAZR expression is downregulated during the transition from the DN stage to the DP stage, and forced expression of MAZR results in variegated expression of CD8 in a proportion of DP thymocytes. Mechanistically, the transcriptional 'off ' state is linked to the nuclear corepressor NCoR, which interacts with the BTB domain of MAZR. On the basis of these observations, MAZR has been proposed to be an important negative regulator of activation of the Cd8 gene complex during the DN-to-DP transition of thymocyte development 9 .
A r t i c l e s
Expression of the coreceptors CD4 and CD8 correlates with the functional phenotype of T cells. Understanding the transcriptional regulation of Cd4 and the adjacent genes Cd8a and Cd8b1 (collectively called 'Cd8' here) might therefore provide insight into the cell-fate 'decision' of DP thymocytes [1] [2] [3] . CD8 expression is tightly regulated during thymocyte development by the activity of at least five different cisregulatory elements 4, 5 . Combined deletion of certain Cd8 enhancers leads to variegated expression of CD8 in CD4 + CD8 + double-positive (DP) thymocytes [6] [7] [8] , and CD8 variegation correlates with an epigenetic 'off ' state 9 . Such studies indicate that there is a complex regulatory network of developmental stage-and subset-specific cis-regulatory elements and link Cd8 enhancer function with chromatin remodeling of the Cd8 gene complex 10 . The transcriptional regulator MAZR (also called PATZ1 or Zfp278) seems to be one of the factors involved in keeping the local chromatin at the Cd8 loci in a transcriptional 'off ' state at the CD4 -CD8 -double-negative (DN) stage 9 . MAZR is encoded by Patz1 (called 'Mazr' here) and belongs to the family of zinc-finger factors that contain a BTB (POZ) domain 11, 12 . Mazr is expressed in the brain, thymocytes and B cells 13 . A study has also reported that MAZR is essential for spermatogenesis 14 . In DN thymocytes, MAZR interacts with several Cd8 cis-regulatory elements. MAZR expression is downregulated during the transition from the DN stage to the DP stage, and forced expression of MAZR results in variegated expression of CD8 in a proportion of DP thymocytes. Mechanistically, the transcriptional 'off ' state is linked to the nuclear corepressor NCoR, which interacts with the BTB domain of MAZR. On the basis of these observations, MAZR has been proposed to be an important negative regulator of activation of the Cd8 gene complex during the DN-to-DP transition of thymocyte development 9 .
To further investigate the physiological function of MAZR during T cell development, we generated Mazr-deficient (Mazr −/− ) mice. Although deletion of MAZR was not sufficient to activate CD8 expression in DN thymocytes, it partially reverted the variegated expression of Cd8 genes in DP thymocytes doubly deficient in the E8 I and E8 II enhancers. Furthermore, mature thymocytes and peripheral T cells of Mazr −/− mice had higher ratios of CD4 + cells to CD8 + cells. By intercrossing Mazr −/− mice with major histocompatibility complex (MHC) class I-restricted T cell antigen receptor (TCR)-transgenic mice and by generating Mazr −/− bone marrow-chimeric MHC class II-deficient mice, we demonstrate that the greater number of CD4 lineage cells in Mazr −/− mice was due in part to redirected differentiation of MHC class I-restricted CD8 + single-positive (CD8SP) thymocytes into the CD4 helper lineage. In addition, we demonstrate derepression of Th-POK (encoded by Zbtb7; called 'Thpok' here), an essential molecule for helper lineage differentiation 15, 16 , in MHC class Isignaled DP and CD4 + CD8 lo Mazr −/− thymocytes. MAZR bound the Thpok silencer, which suggested direct control of Th-POK expression. Thus, our data provide genetic evidence that MAZR is part of the transcription factor network that controls the CD4-versus-CD8 cell-fate 'decision' of DP thymocytes by regulating Th-POK expression.
RESULTS

Altered CD4 + T cell/CD8 + T cell ratios in Mazr −/− mice
We generated Mazr −/− mice by gene-targeting approaches ( Supplementary  Fig. 1 ). Mazr −/− mice were born at a lower Mendelian frequency than expected ( Supplementary Fig. 2a ) and were smaller than their Mazr +/+ littermates ( Supplementary Fig. 2b,c) . As DN and DP thymocytes have high expression of MAZR 9 , we comprehensively analyzed the T cell lineage. The smaller size of Mazr −/− mice correlated with approximately 40% and 50% lower thymocyte and splenocyte numbers, respectively (Fig. 1a) . The expression of CD4, CD8α and CD8β protein was normal in Mazr −/− mice (Fig. 1b,c and data not shown). However, the ratio of CD4SP thymocytes to CD8SP thymocytes was higher in Mazr −/− than in Mazr +/+ mice, and this was most notable in the CD3 hi population (Fig. 1b,d ). In contrast, the expression profile of CD4 and CD8 was similar in Mazr +/+ and Mazr −/− CD3 lo cells (Fig. 1b) . The higher CD4SP cell/CD8SP cell ratio led also to a higher ratio of CD4 + T cells to CD8 + T cells in the peripheral lymphoid organs of Mazr −/− mice (Fig. 1c,d) . However, the expression of several cell surface markers, such as CD62L, CD44, CD25 and CD122, was normal on peripheral CD4 + and CD8 + T cells, with the exception of a slightly larger CD8 + CD44 hi T cell subset in the absence of MAZR ( Supplementary Fig. 3a and data not shown). Moreover, CD25 + Foxp3 + regulatory T cells, CD1d-restricted invariant natural killer T cells, TCRγδ + T cells and CD8αα + TCRγδ + intraepithelial lymphocytes were present at similar frequencies in Mazr +/+ and Mazr −/− mice ( Supplementary Fig. 3b-e) . Mazr −/− mice showed normal B cell development, and all major myeloid subsets were present under homeostatic conditions (data not shown).
MAZR affects CD8 expression
MAZR is proposed to function as a negative regulator of the activation of the Cd8 gene complex during the DN-to-DP transition of thymocyte development 9 . DN thymocytes were still present in Mazr −/− mice (Fig. 1b, bottom) , and the distribution of the DN1-DN4 subsets was similar in Mazr +/+ and Mazr −/− mice ( Supplementary Fig. 3f,g ). This indicated that the early stages of thymocyte development were not affected by the loss of MAZR and that the deletion of MAZR was not sufficient to activate expression of Cd8a and Cd8b1 in DN thymocytes.
Combined deletion of the Cd8 enhancers E8 I and E8 II leads to variegation of CD8 in DP thymocytes 6 , which correlates with epigenetic differences at the Cd8 gene complex 9 . We hypothesized that in the absence of E8 I and E8 II , fewer positive factors would be recruited to the Cd8 loci in DP thymocytes, which would thus change the balance between the closed and open state of chromatin. As MAZR is one of the negative factors that control the Cd8 gene complex, reversion of CD8 variegation would be expected in mice doubly deficient in E8 I and E8 II in the absence of MAZR. To test our hypothesis, we intercrossed Mazr −/− mice with mice doubly deficient in E8 I and E8 II . The number of viable Mazr −/− offspring from heterozygous intercrosses were much lower for mice backcrossed onto the C57BL/6 background (S.S. and W.E., unpublished data). Therefore, we transferred Mazr +/+ and Mazr −/− fetal liver cells (CD45.2 + ) at embryonic day 13.5, on an E8 I E8 II -deficient background, into irradiated CD45.1 + congenic mice. As reported before 6 , there was a strong CD8 variegation in Mazr +/+ E8 I E8 II -deficient thymocytes. However, CD8 variegation was much lower in Mazr −/− E8 I E8 II -deficient thymocytes (Fig. 2a, top) , and this was even more evident in the CD3 lo subset that represents mainly DP thymocytes (Fig. 2a, bottom,  and 2b) . These findings provide genetic evidence that MAZR is an essential negative regulator of CD8 expression during the DN-to-DP transition, as proposed before 9 .
T cell-intrinsic defects in Mazr −/− mice The lower thymocyte and T cell numbers could have been the consequence of the smaller size of Mazr −/− mice or a T cell-intrinsic defect (Fig. 3a , top, and 3b). This indicates that the lower T cell numbers in Mazr −/− mice were a consequence of the smaller size of Mazr −/− mice. In contrast, whereas the expression profiles of CD4 and CD8 on thymocytes and peripheral T cells derived from Mazr +/+ (CD45.2 + ) bone marrow cells was normal, the ratio of CD4 + T cells to CD8 + T cells was higher in the Mazr −/− bone marrow-derived (CD45.2 + ) T cell compartment (Fig. 3a , bottom, and 3c). This showed that the altered ratios of CD4SP to CD8SP thymocytes and CD4 + T cells to CD8 + T cells in Mazr −/− mice was a T cell-intrinsic defect.
Partial redirection of MHC class I-restricted thymocytes
To investigate the reason for the higher ratio of CD4 + T cells to CD8 + T cells, we crossed Mazr +/+ and Mazr −/− mice with OT-I or OT-II TCRtransgenic mice, which express TCRs (β-chain variable region 5 (V β 5) and V α 2) restricted to MHC class I or class II, respectively 17, 18 . The thymic expression profile of CD4 and CD8 in Mazr −/− OT-II mice was similar to that in Mazr +/+ OT-II mice ( Fig. 4a and Supplementary Fig. 4a ).
In the periphery, there was a slightly higher percentage of CD4 + T cells and correspondingly lower frequency of CD8 + T cells in Mazr −/− OT-II mice; however, the percentage of transgenic V α 2-expressing T cells was similar ( (Fig. 5a ). This resulted in a much higher absolute number of CD4 + T cells in Mazr −/− Rag2 −/− OT-I chimeric mice than in Mazr +/+ Rag2 −/− OT-I chimeric mice (Fig. 5b) . Moreover, the MHC class I-restricted CD4 + T cells in Mazr −/− Rag2 −/− OT-I chimeric mice had features characteristic of helper T cells, such as expression of Thpok and upregulation of CD154 (CD40L) after activation, but they produced small amounts of interferon-γ (IFN-γ) and did not express Prf1 (which encodes perforin; Supplementary Fig. 5a-c) . Of note, most of the Mazr −/− Rag2 −/− OT-I CD4 + T cells were CD44 lo CD62L hi (Supplementary Fig. 5d ), which suggested that they were not innate-like T cells (such as invariant natural killer T cells).
Next we investigated whether MHC class I-restricted MAZR-deficient CD4 + T cells also developed in a non-TCR-transgenic setting. We transplanted Mazr +/+ and Mazr −/− (CD45.2 + ) bone marrow cells into MHC class II-deficient (CD45.1 + ) recipients and determined the number of peripheral T cells and thymocytes after reconstitution. There was a significantly higher percentage and absolute number of CD3 + CD4 + T cells (CD45.2 + ) and a correspondingly lower number of CD3 + CD8 + T cells in the spleen and thymus of Mazr −/− chimeric mice than in those of Mazr +/+ chimeras (Fig. 5c,d and Supplementary Fig. 6a,b) . To exclude innate-like T cells such as invariant natural killer T cells, we analyzed only CD1d tetramer-negative cells. We also detected a similar increase in CD4 lineage cells for TCRαβ + -gated T cells (to exclude γδT cells; data not shown). We noticed that most Mazr +/+ and Mazr −/− CD4 + T cells were CD44 hi , most probably because of altered homeostasis in an MHC class II-deficient environment (Supplementary Fig. 6 ). However, there was no difference between Mazr +/+ and Mazr −/− MHC class IIdeficient chimeras in the percentage of IFN-γ-producing CD44 hi T cells after stimulation with phorbol 12-myristate 13-acetate and ionomycin ( Supplementary Fig. 6c ), which indicated that the greater number of Mazr −/− CD4 + T cells was not due to a greater number of innate-like T cells. Together the data obtained with MHC class I-restricted TCR transgenic mice and bone marrow-chimeric MHC class II-deficient mice indicated that a fraction of Mazr −/− MHC class I-restricted thymocytes were redirected into the helper T cell lineage.
Derepression of Thpok in MAZR-deficient thymocytes
Molecules such as Th-POK, Runx1, Runx3, GATA-3 and Tox have been linked to the CD4 or CD8 lineage commitment of DP thymocytes 15, 16, [19] [20] [21] [22] [23] [24] . To investigate whether loss of MAZR induced alterations in the expression of these factors, we did quantitative real-time PCR analysis of the following sorted thymocyte subsets from mice given transplantation of Mazr +/+ Rag2 −/− OT-I or Mazr −/− Rag2 −/− OT-I fetal liver: CD69 -V α 2 lo DP (DP CD69 -; preselected DP cells); CD69 + V α 2 int-hi DP (DP CD69 + ; signaled DP cells); and CD69 + V α 2 int-hi CD4 + CD8 lo (CD4 + CD8 lo CD69 + ). The DP CD69 -and DP CD69 + subsets of Mazr −/− Rag2 −/− OT-I chimeric mice had higher expression of Thpok than did those of Mazr +/+ Rag2 −/− OT-I chimeric mice. In contrast, expression of Runx1, Runx3, Gata3 and Tox was similar in the Mazr −/− Rag2 −/− OT-I and Mazr +/+ Rag2 −/− OT-I DP subsets (both CD69 -and CD69 + ), whereas Runx3 expression was lower in the CD4 + CD8 lo CD69 + subsets ( Fig. 6a and Supplementary Fig. 7 ).
To investigate in detail the expression pattern of Th-POK in MAZR-deficient thymocytes, we crossed Mazr −/− OT-I mice with a Th-POK-GFP reporter mouse in which cDNA encoding green fluorescent protein (GFP) is inserted into the Thpok locus (Thpok +/GFP ) 20 ; thus, GFP expression is driven by the endogenous Thpok regulatory elements. Th-POK expression is induced mainly by MHC class II signaling, and after positive selection, a large fraction of CD4 + CD8 lo CD69 + thymocytes expresses Th-POK 15, 16, 20, 21, 25 . However, some Th-POKexpressing CD4 + CD8 lo CD69 + cells retain the potential to develop into the cytotoxic cell lineage 21, 25 . During CD4 lineage differentiation, Thpok mRNA expression is upregulated and all CD4SP thymocytes and CD4 + T cells have high expression of Th-POK, whereas only a small population of CD8SP thymocytes and peripheral CD8 + T cells have very low expression of Th-POK 21, 25 . In Mazr +/+ Thpok +/GFP OT-I mice, we detected GFP + cells in the DP CD69 + and in CD4 + CD8 lo CD69 + populations ( Fig. 6b and Supplementary Fig. 8a ). The percentage of GFP + cells increased almost 100% in the CD4SP subset, whereas CD8SP thymocytes terminated GFP expression. Consistent with the 
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quantitative real-time PCR data, a substantial number of GFP + cells appeared in the DP CD69 -thymocyte populations of Mazr −/− Thpok +/GFP OT-I mice ( Fig. 6b and Supplementary Fig. 8a ), which indicated derepression of Th-POK. Moreover, the percentage of GFP + cells in the DP CD69 + and CD4 + CD8 lo CD69 + populations of Mazr −/− Thpok +/GFP OT-I thymocytes was greater than that of Mazr +/+ Thpok +/GFP OT-I thymocytes (Fig. 6b) . Endogenous Thpok expression was already lower in CD8SP cells than in CD4SP cells (Supplementary Fig. 9a,b) , even though a fraction of CD8SP cells remained GFP hi (Fig. 6b) , most probably because of slow GFP protein degradation, Notably, peripheral CD8 + T cells in Mazr −/− Thpok +/GFP OT-I mice expressed GFP, although in lower amounts than that of CD4 + T cells (Fig. 6b) , consistent with the observation that we detected Thpok expression in CD8 + T cells of Mazr −/− Rag2 −/− OT-I mice (Supplementary Fig. 5c ).
To determine whether Th-POK was also derepressed in a non-TCRtransgenic setting, we analyzed GFP expression in Mazr −/− Thpok +/GFP mice. We did not detect GFP expression (or Thpok mRNA expression) in Mazr −/− DP CD69 − thymocytes (Fig. 7a and data not shown), which suggested that MAZR is not essential for Th-POK repression in presignaled DP cells. However, we found a higher percentage of GFP + DP CD69 + and CD4 + CD8 lo CD69 + thymocyte subsets (CD69 + TCRβ int-hi DP and CD69 + TCRβ int-hi CD4 + CD8 lo subsets) in Mazr −/− Thpok +/GFP mice than in Mazr +/+ Thpok +/GFP mice, whereas CD8SP cells terminated GFP expression (Fig. 7a and Supplementary Fig. 8b ). Similar to results obtained with Mazr −/− Thpok +/GFP OT-I mice, a fraction of peripheral CD8 + T cells in Mazr −/− Thpok +/GFP mice re-expressed GFP (Fig. 7a) , which indicated that MAZR is needed to maintain Th-POK repression in CD8 + T cells. Next we determined whether TCR interactions with either MHC class I or MHC class II induced higher percentages of GFP + cells. Therefore, we transferred bone marrow cells from Fig. 7b and Supplementary  Fig. 8c ). This indicated derepression of Th-POK in Mazr −/− thymocytes in MHC class I-signaled thymocytes.
To provide mechanistic insight into how MAZR is involved in Th-POK repression, we tested whether MAZR could bind a newly identified Thpok silencer that is indispensable for the helper lineage-specific expression of Th-POK 20, 26 . Chromatin-immunoprecipitation (ChIP) assays showed that MAZR bound to the Thpok silencer region (Fig. 7c) . This result suggested direct regulation of Thpok by MAZR. Because Runx transcription factor complexes bind to the Thpok silencer 20 , we investigated whether MAZR interacts with Runx1 and Runx3. We detected association of MAZR with Runx1 but not with Runx3 after overexpression of MAZR with either Runx1 or Runx3 in HEK293T human embryonic kidney cells (Supplementary Fig. 10 ). Thus, MAZR might repress ThPOK expression through interactions with Runx1 complexes (model of MAZR function, Supplementary Fig. 11 ).
DISCUSSION
In this study we have provided evidence that the transcriptional regulator MAZR has important functions at two distinct stages of T cell development. MAZR is a negative regulator of the Cd8 gene complex during the DN-to-DP transition. It also represses Th-POK expression in MHC class Isignaled thymocytes during the CD4-versus-CD8 cell-fate 'decision' .
First we observed that the deletion of MAZR almost completely reversed CD8 variegation in mice doubly deficient in the Cd8 E8 I and E8 II enhancers. Thus, our data provide genetic evidence that MAZR negatively regulates the activation of the Cd8 loci during the DN-to-DP transition. MAZR binds to Cd8 enhancers and interacts with the nuclear corepressor NCoR complex in thymocytes 9 . NCoR is a component of many protein complexes that also contain histone deacetylases that repress target genes 27 . Therefore, MAZR might repress Cd8 expression through the recruitment of repressor complexes containing NCoR. On the basis of that model, reversion of CD8 variegation would be expected in mice doubly deficient in E8 I and E8 II in the absence of MAZR. We did indeed observe this. Thus, our results indicate that the balance between negative and positive factors at the Cd8 gene complex can determine the initiation of expression of Cd8a and Cd8b1. Even though the Cd8 loci are released from MAZR-mediated repression in the absence of MAZR, positive factors required for CD8 expression might not be sufficiently available in DN thymocytes. In contrast, in the absence of E8 I and E8 II , fewer positive factors are recruited to the Cd8 loci in DP thymocytes, which leads to CD8 variegation. However, deletion of the negative regulator MAZR in DP cells doubly deficient in E8 I and E8 II shifts the balance at the Cd8 loci toward an 'on' state and thus facilitates CD8 expression.
A second result of our study is the demonstration that MAZR is part of the transcription factor network that controls the CD4-versus-CD8 cellfate specification of DP thymocytes. Several transcription factors (such as Th-POK, Runx1, Runx3, GATA-3 and Tox) act in a complex regulatory network that orchestrates this cell-fate 'decision' 15, 16, [19] [20] [21] [22] [23] [24] [28] [29] [30] . Among those, Th-POK is considered a master CD4-commitment factor, acting in part by shutting off lineage-inappropriate genes 21, 22, 31, 32 . Therefore, the regulation of Th-POK expression is crucial for the correct lineage 'choice' . We have now shown that in the absence of MAZR, a substantial proportion of MHC class I-restricted thymocytes were redirected into CD4 + T cells with helper-lineage characteristics because of derepression of Th-POK. We demonstrated this by intercrossing Mazr −/− mice with MHC class I-restricted TCR-transgenic mice and by generating Mazr −/− bone marrow-chimeric MHC class II-deficient mice. Although only a minor subset of Mazr +/+ DP 69 + and CD4 + CD8 lo CD69 + cells have low expression of Thpok mRNA in response to MHC class I stimulation 15, 16, 20, 21, 25 , a greater percentage of these cells derepressed Th-POK in the absence of MAZR, which provides a potential molecular explanation for the redirected differentiation of Mazr −/− thymocytes. This suggests a role for MAZR in repressing Th-POK expression in MHC class I-signaled thymocytes during positive selection.
The Thpok silencer is required for Th-POK repression and cytotoxiclineage development 20, 26 . Runx complexes are essential for Th-POK repression at the preselection DP CD69 − stage via binding to the Thpok silencer 20, 21, 29 . We cannot formally exclude the possibility that MAZR regulates Th-POK expression indirectly, for example, by regulating the expression of Runx3 in CD4 + CD8 lo cells, which would then lead to altered expression of Th-POK. Alternatively, MAZR might have pleiotropic effects on gene expression; for example, it might regulate the expression of a factor involved in TCR signaling. This could lead to qualitative and/or quantitative changes in TCR signaling and, as a consequence, changes in Th-POK expression. However, our ChIP results showing that MAZR bound to the Thpok silencer suggest direct control of the Thpok locus by MAZR. We speculate that MAZR represses Th-POK expression in cooperation with Runx complexes in MHC class I-signaled cells. The expression of Runx1 and Runx3 was normal in DP thymocytes, and Runx complexes were still bound to the Thpok silencer in the absence of MAZR (data not shown), which indicates that the recruitment of Runx complexes is independent of MAZR. As we detected association of MAZR with Runx1 but not with Runx3 after overexpression of MAZR with either Runx1 or Runx3 in HEK293T cells, MAZR might be recruited to the Thpok silencer through interaction with Runx complexes that are bound already to the Thpok silencer. Alternatively, the recruitment of MAZR to the Thpok silencer could occur independently of Runx complexes; however, the interaction between MAZR and Runx complexes might be necessary for the recruitment of additional factors to repress Th-POK. Further studies are needed to investigate the potential mechanism(s) of Th-POK repression mediated by MAZR-Runx interactions. Moreover, as Runx1 promotes the expression of CD8 in unsignaled DP thymocytes 19 , and as MAZR regulates activation of the Cd8 gene complex, future studies should also address whether MAZR-Runx1 interactions might regulate CD8 expression during the DN-to-DP transition.
We also observed that a fraction of peripheral MAZR-deficient CD8 + T cells expressed Th-POK. This suggests that MAZR might also be part of the molecular machinery that maintains Th-POK silencing in CD8 + T cells. A study has demonstrated that certain DNase Ihypersensitive sites in the Thpok locus 'preferentially' appear in CD4SP thymocytes, which supports the idea that Th-POK expression is accompanied by structural changes of chromatin 26 . Given the variegated expression of Th-POK in Mazr −/− Thpok +/GFP CD8 + T cells, MAZR might regulate Th-POK expression at the epigenetic level, in a manner similar to the way it regulates Cd8 expression 9 . In contrast to CD8 + T cells, CD8SP thymocytes in Mazr −/− Thpok +/GFP mice did not express Th-POK. This suggests different mechanisms of Th-POK silencing in CD8SP thymocytes and CD8 + T cells, a situation reminiscent of the transcriptional control of Cd4 silencing, in which the Cd4 silencer is required in different ways in CD8SP thymocytes versus CD8 + T cells 19, 33, 34 . Further analysis is needed to elucidate the molecular mechanism(s) by which MAZR shuts off Th-POK expression and/or maintains Th-POK silencing in CD8 lineage cells. Thus, in MHC class I-signaled CD4 + CD8 lo thymocytes, MAZR is involved in keeping the Thpok locus repressed during CD8 lineage differentiation, and/or in peripheral CD8 + T cells, MAZR probably functions in the establishment and/or maintenance of Thpok silencing. Of note, MHC class I-and MHC class II-signaled CD4 + CD8 lo thymocytes had similar expression of Mazr mRNA (data not shown), and MAZR bound the Thpok silencer in DN, DP, CD4SP and CD8SP thymocytes (data not shown). These data suggest that Th-POK repression by MAZR in MHC class I-signaled cells is not due to differences in MAZR expression or differences in its recruitment to the Thpok locus.
We observed that Th-POK was derepressed in a proportion of MHC class I-signaled Mazr −/− Thpok +/GFP thymocytes and that Thpok mRNA expression was broadly distributed, which led to cells with higher and lower expression of Th-POK. It might be possible that only those thymocytes in which derepressed Th-POK expression remains above a certain threshold are redirected into the helper lineage, which therefore leads to a partial redirection phenotype. In contrast, if derepression of Th-POK is below a certain threshold, the differentiation of these cells into the cytotoxic lineage is impaired. Th-POK expression might even be regulated by TCR strength. Indeed, in contrast to results obtained with the OT-I TCR-transgenic system, thymocytes expressing the MHC class I-restricted P14-transgenic TCR were not redirected by loss of MAZR, although CD8 lineage development was severely impaired (data not shown). A similar dependency on the transgenic TCR system has been observed in GATA-3-deficient mice, in which redirected differentiation of MHC class II-restricted thymocytes occurs on the 5C.C7 TCR-transgenic background but not on the AND or DO11.10 TCR-transgenic background 22 . Further studies are needed to clarify the potential relation between TCR signaling strength and Th-POK derepression in the absence of MAZR, and the subsequent effect on the CD4-versus-CD8 cell-fate 'decision'.
Together our data have provided genetic evidence that MAZR controls the Cd8 loci. Moreover, our study has shown that loss of MAZR led to derepression of Th-POK, which caused redirected differentiation of MHC class I-restricted thymocytes into helper T cells. Thus, MAZR is part of the transcription factor network that controls the fate of DP thymocytes.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
